Published January 12, 2022
POP Biotechnologies Inc. (POP BIO) is one four startups founded or co-founded by University at Buffalo researchers that has received Small Business Innovation Research (SBIR) awards from the National Institutes of Health to advance research on potential vaccines or therapies for a variety of diseases.
POP BIO has received $599,982 from the National Institute of Allergy and Infectious Diseases to develop a liposome-based COVID-19 vaccine that could be freeze-dried and then stored at room temperature, eliminating logistical challenges that can impact vaccination campaigns, such as needs for ultra-cold storage.
The Department of Biomedical Engineering is a joint program between the Jacobs School of Medicine and Biomedical Sciences and UB’s School of Engineering and Applied Sciences.
“For startups and small businesses like POP BIO, which is a company implementing inventive and beneficial concepts, funding like this is important,” says Allison Brashear, MD, UB’s vice president for health sciences and dean of the Jacobs School.
“In the United States, NIH small business programs are one of the biggest sources of early-stage capital for the life sciences. This NIH funding will help enable Dr. Lovell and his fellow scientists continue to translate their research into reality,” she adds.
The other startups which received NIH funding are:
All four startups have received technology transfer assistance and other support through UB’s Business and Entrepreneur Partnerships (BEP) team. Faculty founders of three — Abceutics, Immune Modulatory Therapies and Transira Therapeutics — received awards from the Buffalo Innovation Accelerator Fund administered by BEP.
The university provides a range of support to faculty entrepreneurs, including seed funding, help with patent and grant applications, opportunities to locate in incubators, and assistance in identifying experienced entrepreneurs and business teams who can help move innovations to market.
“UB researchers pioneer life-changing innovations every day,” says Christina Orsi, UB associate vice president for economic development. “By supporting them with guidance, funds and space, and partnering them with business experts to serve as company leaders, we can advance those innovations into the world to really change lives.”